Literature DB >> 1810590

Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro.

C W Jiang1, P M Sarrel, D C Lindsay, P A Poole-Wilson, P Collins.   

Abstract

1. We assessed the relaxant effect of 17 beta-oestradiol (10(-7), 10(-6) and 10(-5) M) on rabbit isolated coronary arteries precontracted with prostaglandin F2 alpha (3 x 10(-6) M), high extracellular potassium (30 mM) and Bay K 8644 (10(-6) M) plus high extracellular potassium (15 mM) by measuring isometric tension. 17 beta-Oestradiol (10(-6) and 10(-5) M) induced significant relaxation in coronary arteries from male and female rabbits. No differences were seen between arteries with or without endothelium. There were also no differences between coronary arteries isolated from male and female rabbits. 2. Inhibitors of endothelium-derived relaxing factor and vasodilator prostanoids, namely, reduced haemoglobin, N omega-nitro-L-arginine methyl ester and indomethacin, did not affect the relaxation induced by 17 beta-oestradiol in endothelium-intact coronary arteries. 3. Methylene blue, an inhibitor of guanylate cyclase, did not affect the coronary artery relaxation induced by 17 beta-oestradiol. 4. The calcium concentration-dependent contraction curve in potassium-depolarization medium was shifted to the right by 17 beta-oestradiol (10(-6) and 10(-5) M) in the rabbit coronary artery and rat aorta. The -log EC50s of calcium in control and after incubation with 17 beta-oestradiol (10(-6) and 10(-5) M) were 3.7 +/- 0.09, 3.1 +/- 0.10 and 2.8 +/- 0.08 respectively in rabbit coronary arteries and 3.8 +/- 0.11, 3.3 +/- 0.14 and 2.9 +/- 0.15 in rat aorta. 5. The results indicate that 17 beta-oestradiol induces rabbit coronary artery relaxation by an endothelium-independent mechanism in vitro. A calcium antagonistic property may be involved in the mechanism of rabbit coronary arterial relaxation by 17beta-oestradiol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810590      PMCID: PMC1908863          DOI: 10.1111/j.1476-5381.1991.tb12545.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

2.  Indomethacin and aspirin abolish prostaglandin release from the spleen.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

3.  Effect of the calcium antagonist nifedipine on uterine blood flow in non-treated and oestradiol-treated rats.

Authors:  B Sandahl; K E Andersson; K F Aronsen; U Ulmsten
Journal:  Gynecol Obstet Invest       Date:  1978       Impact factor: 2.031

4.  The inhibitory action of oestradiol-17-beta and progesterone on venous smooth muscle.

Authors:  T A McCalden
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Oestrogen-induced sensitization of the uterine artery of the guinea-pig to acetylcholine.

Authors:  C Bell
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

7.  Oestrogen therapy and the menopausal syndrome.

Authors:  S Campbell; M Whitehead
Journal:  Clin Obstet Gynaecol       Date:  1977-04

8.  Menopause and risk of cardiovascular disease: the Framingham study.

Authors:  W B Kannel; M C Hjortland; P M McNamara; T Gordon
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391

9.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

10.  Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

Authors:  P D Henry; K I Bentley
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  42 in total

1.  Enhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17beta-estradiol involves non-genomic mechanisms and the cyclic AMP cascade.

Authors:  H Teoh; R Y Man
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation.

Authors:  C R Rosenfeld; B E Cox; T Roy; R R Magness
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

Authors:  M Seed
Journal:  Drugs       Date:  1994       Impact factor: 9.546

Review 4.  Estrogen effects in the heart.

Authors:  T Pelzer; A Shamim; L Neyses
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

5.  Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.

Authors:  Eric Thorin; Mylan Pham-Dang; Robert Clement; Isabelle Mercier; Angelino Calderone
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

Review 6.  Syndrome X--angina and normal coronary angiography.

Authors:  A Chauhan
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

7.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

9.  Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry.

Authors:  Fernando P Filgueira; Núbia S Lobato; Denise L Nascimento; Graziela S Ceravolo; Fernanda R C Giachini; Victor V Lima; Ana Paula Dantas; Zuleica B Fortes; R Clinton Webb; Rita C Tostes; Maria Helena C Carvalho
Journal:  Steroids       Date:  2018-11-17       Impact factor: 2.668

Review 10.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.